Crescent Biopharma CBIO
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2026Q1 | 18.37 | 184 | -12.04 | -23 | -10.6 | 199 |
| 2025Q4 | 11.86 | 203 | -57.81 | -92 | -48.81 | 240 |
| 2025Q3 | 11.89 | 117 | -19.23 | -25 | -16.64 | 138 |
| 2025Q2 | 16.14 | 139 | -30.55 | -22 | -26.67 | 157 |
| 2025Q1 | 21 | 3 | -53.95 | -2 | -27.44 | 6 |
| 2024Q4 | 24.9 | 5 | -86.55 | -7 | -53.93 | 11 |
| 2024Q3 | 16.9 | 11 | -62.5 | -10 | -48.98 | 16 |
| 2023Q3 | 4 | -2 | -14.1 | 10 | ||
| 2023Q2 | -28 | -2 | -15.87 | 12 | ||
| 2023Q1 | -26 | 0 | 1.1 | 19 | ||
| 2022Q4 | -22 | -40 | -136.06 | 28 | ||
| 2022Q3 | 29 | -9.01 | -5 | -8.54 | 31 | |
| 2022Q2 | 79 | 97.28 | 52 | 83.52 | 83 | |
| 2022Q1 | 27 | -42.64 | -15 | -30.3 | 40 | |
| 2021Q4 | 41 | -39.93 | -20 | -30.3 | 56 | |
| 2021Q3 | 61 | -34.6 | -25 | -27.99 | 79 | |
| 2021Q2 | 85 | -21.06 | -20 | -18.05 | 102 | |
| 2021Q1 | 104 | -24.91 | -22 | -20.98 | 119 | |
| 2020Q4 | 76 | -22.23 | -19 | -18.3 | 95 | |
| 2020Q3 | 94 | -15.79 | -16 | -13.62 | 112 |